Get started
Author

Eric Fromentin

Observed names: Fromentin, Eric, Éric Fromentin
ORCID: 0009-0008-4577-9624
Observed ORCID: 0009-0008-4577-9624
OpenAlex ID: A5066894507
Creating a French Dataset for artificial intelligence-assisted allergy diagnosis using semantic attributes and allergen multiplex technology
2023 · Guillaume Martinroche, Julien Goret, et al. · Journal of Allergy and Clinical Immunology · 4
PDF
Allergen Chip Challenge: A nationwide open database supporting allergy prediction algorithms
2025 · Guillaume Martinroche, Amir Guemari, et al. · Journal of Allergy and Clinical Immunology · 2
Baseline Serum Tryptase: Sex‐ and Age‐Specific Reference Intervals in the Pediatric and Adult Population
2025 · Yannick Chantran, Hélène Novakowski, et al. · Allergy · 2
PDF
Allergic rhinitis activity and efficacy of 300 IR house dust mite sublingual immunotherapy tablet in pediatrics
2026 · Philippe Devillier, Mitsuhiro Okano, et al. · Pediatric Allergy and Immunology · 1
Towards an artificial intelligence-assisted allergy diagnosis using semantic attributes and allergen multiplex technology
2024 · Guillaume Martinroche, Julien Goret, et al. · Journal of Allergy and Clinical Immunology · 1
De l’environnement à l’anticorps thérapeutique : nouvelles clés pour comprendre, prévenir et guérir les maladies allergiques
2026 · Joana Vitte, Caroline Klingebiel, et al. · Questions de santé publique
Administration of liquid sublingual immunotherapy using the iPUMP: The real-life SPEED study
2026 · Julien Cottet, Éric Fromentin, et al. · Journal of Allergy and Hypersensitivity Diseases
Real-world use of sublingual immunotherapy and shared decisions in French observational study PRACTIS
2026 · Habib Chabane, Isabelle Bossé, et al. · Journal of Allergy and Hypersensitivity Diseases
Open source release of the Allergen Chip national French database of clinical and multiplex IgE data
2025 · Martinroche, Guillaume, Goret, Julien, et al. · HAL
Contribution de l’assistant connecté iPUMP© à la bonne observance pour des patients initiant une immunothérapie allergénique sous-linguale (Staloral©) : étude pilote de phase 1 en situation de vie réelle
2024 · R. Montagne, J. Cottet, et al. · Revue française d'allergologie
Works count: 10
Citation count: 10
H-index: 2
I10-index:
Year
Topic
Type